Discover 1,440 paid clinical trials in Quebec. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 1,440
Study of COYA 302 for the Treatment of ALS
for
Amyotrophic Lateral Sclerosis (ALS)
Location: Boston MA, New York NY, Montreal, Philadelphia PA,
Sponsor: Coya Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07161999
Phase2, Phase3, Recruiting
Implementation of Support in the Care of Adults Living With Type 1 Diabetes
for
Type 1 Diabetes, Metabolic Disease, Endocrine System Diseases,
Location: Quebec, Montreal, Terrebonne
Sponsor: McGill University
Sex: All
Age: 18+
Code: NCT06069583
Recruiting
Evaluating the Feasibility of elleFA App Implementation
for
Endometriosis
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Sex: Female
Age: 18+
Code: NCT06452407
Recruiting
Minimal Effective Volume 90% for Double-injection Costoclavicular Block
for
Brachial Plexus Blocks, Lidocaine, Nerve Block,
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Sex: All
Age: 18 - 70
Code: NCT07374952
Recruiting
Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)
for
Malignant Neoplasm
Location: Montreal, San Antonio TX
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07600749
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Home-based Exercise Therapy in Patients With Moderate to Severe Peripheral Artery Disease
for
Peripheral Artery Disease
Location: Levis
Sponsor: Laval University
Sex: All
Age: 18+
Code: NCT07655206
Recruiting
Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors
for
Breast Cancer, Non-small Cell Lung Cancer (NSCLC),
Location: Montreal, Omaha NE
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07660055
Phase1, Recruiting
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
for
Plaque Psoriasis
Location: St. John's, Portsmouth NH, Brighton MA, Milford MA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 40+
Code: NCT07116967
Phase3, Recruiting
A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)